HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yue Lu Selected Research

Integrins

10/2021Low incidence rate of diarrhoea in COVID-19 patients is due to integrin.
1/2021MFG-E8 attenuates inflammation in subarachnoid hemorrhage by driving microglial M2 polarization.
1/2018Recombinant milk fat globule-EGF factor-8 reduces apoptosis via integrin β3/FAK/PI3K/AKT signaling pathway in rats after traumatic brain injury.
2/2014Adenovirus-mediated delivery of the human IFN-γ gene potentiates the cytotoxicity of daunorubicin against leukemic cells through downregulation of the α4β1 integrin/ILK/apoptosis pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yue Lu Research Topics

Disease

87Neoplasms (Cancer)
05/2024 - 01/2008
30Inflammation (Inflammations)
11/2023 - 01/2010
23Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
04/2024 - 01/2017
15Psoriasis (Pustulosis Palmaris et Plantaris)
03/2024 - 07/2016
14Prostatic Neoplasms (Prostate Cancer)
01/2022 - 05/2011
14Lymphoma (Lymphomas)
12/2020 - 11/2012
13Leukemia
12/2023 - 08/2005
12Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
04/2024 - 08/2011
11Multiple Myeloma
05/2024 - 08/2015
11Parkinson Disease (Parkinson's Disease)
01/2024 - 01/2021
11Carcinogenesis
11/2023 - 08/2011
11Brain Injuries (Brain Injury)
07/2022 - 01/2017
10Infections
01/2024 - 03/2007
8Breast Neoplasms (Breast Cancer)
01/2024 - 03/2014
8Asthma (Bronchial Asthma)
01/2023 - 09/2009
8Anaphylaxis (Anaphylactic Shock)
01/2021 - 12/2011
7Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2023 - 06/2012
7Neoplasm Metastasis (Metastasis)
10/2022 - 12/2004
6Hypoxia (Hypoxemia)
05/2023 - 01/2017
6Traumatic Brain Injuries (Traumatic Brain Injury)
05/2023 - 01/2018
6Fibrosis (Cirrhosis)
01/2023 - 11/2019
6Necrosis
01/2021 - 12/2014
6T-Cell Lymphoma (Lymphoma, T Cell)
11/2020 - 01/2013
6Extranodal NK-T-Cell Lymphoma
05/2016 - 01/2015
5Disease Progression
01/2023 - 01/2011
5Stroke (Strokes)
10/2022 - 12/2016
5Insulin Resistance
01/2022 - 01/2013
5Body Weight (Weight, Body)
01/2021 - 01/2013
5Colitis
12/2019 - 01/2017
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2023 - 01/2021
4Residual Neoplasm
01/2023 - 02/2012
4Aplastic Anemia (Anemia, Hypoplastic)
12/2022 - 01/2016
4Pancreatic Neoplasms (Pancreatic Cancer)
07/2022 - 06/2017
4Melanoma (Melanoma, Malignant)
03/2022 - 11/2016
4Ischemic Stroke
10/2021 - 12/2016
4Brain Ischemia (Cerebral Ischemia)
01/2021 - 12/2016
4Hypersensitivity (Allergy)
01/2021 - 03/2012
4BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
02/2014 - 08/2005
3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
04/2024 - 11/2017
3Autoimmune Diseases (Autoimmune Disease)
03/2024 - 04/2009
3Obesity
01/2024 - 01/2019
3Stomach Neoplasms (Stomach Cancer)
11/2023 - 01/2012
3Hematologic Neoplasms (Hematological Malignancy)
11/2023 - 01/2022
3Hypertension (High Blood Pressure)
10/2023 - 01/2018
3Hepatocellular Carcinoma (Hepatoma)
06/2023 - 12/2013
3Wounds and Injuries (Trauma)
05/2023 - 01/2019
3Glioblastoma (Glioblastoma Multiforme)
01/2023 - 02/2013

Drug/Important Bio-Agent (IBA)

33Proteins (Proteins, Gene)FDA Link
03/2024 - 10/2007
20Biomarkers (Surrogate Marker)IBA
01/2024 - 01/2012
15CytokinesIBA
01/2023 - 08/2005
13RNA (Ribonucleic Acid)IBA
02/2024 - 01/2014
12DNA (Deoxyribonucleic Acid)IBA
12/2023 - 06/2009
9Asparaginase (Elspar)FDA Link
01/2018 - 07/2012
8Therapeutic UsesIBA
03/2024 - 06/2010
8MicroRNAs (MicroRNA)IBA
01/2024 - 11/2016
8Messenger RNA (mRNA)IBA
11/2023 - 09/2009
8Glucose (Dextrose)FDA LinkGeneric
01/2021 - 01/2013
7Sirtuin 1IBA
04/2024 - 01/2019
7Imiquimod (Aldara)FDA LinkGeneric
03/2024 - 07/2016
7Immunoglobulin E (IgE)IBA
01/2021 - 10/2010
6Small Interfering RNA (siRNA)IBA
05/2023 - 03/2014
6Indicators and Reagents (Reagents)IBA
01/2023 - 09/2015
6Interleukin-6 (Interleukin 6)IBA
10/2022 - 01/2019
6OvalbuminIBA
01/2021 - 09/2009
5LigandsIBA
11/2023 - 12/2014
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2023 - 08/2010
5LipidsIBA
01/2023 - 07/2013
5EnzymesIBA
07/2022 - 02/2016
5AMP-Activated Protein KinasesIBA
09/2014 - 01/2013
4Chimeric Antigen ReceptorsIBA
04/2024 - 01/2023
4AcidsIBA
03/2024 - 10/2014
4Neuroprotective AgentsIBA
11/2023 - 01/2019
4coactivator-associated arginine methyltransferase 1IBA
01/2023 - 01/2018
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2023 - 11/2012
4IntegrinsIBA
10/2021 - 02/2014
4pegaspargase (Oncaspar)FDA Link
11/2020 - 05/2016
4Phosphotransferases (Kinase)IBA
01/2020 - 02/2013
4Transcription Factors (Transcription Factor)IBA
01/2019 - 07/2009
4Doxorubicin (Adriamycin)FDA LinkGeneric
01/2019 - 11/2012
4GemcitabineFDA Link
06/2016 - 03/2014
4Oxaliplatin (Eloxatin)FDA LinkGeneric
06/2016 - 03/2014
4Anti-Allergic Agents (Antiallergic Agents)IBA
01/2016 - 12/2011
4kirenolIBA
02/2014 - 09/2011
3Bortezomib (Velcade)FDA Link
05/2024 - 01/2016
3NF-kappa B (NF-kB)IBA
05/2024 - 07/2009
3Peptides (Polypeptides)IBA
01/2024 - 01/2018
3Apolipoproteins E (ApoE)IBA
01/2024 - 11/2019
3Tacrolimus (Prograf)FDA LinkGeneric
12/2023 - 01/2010
3LipopolysaccharidesIBA
11/2023 - 12/2019

Therapy/Procedure

56Therapeutics
05/2024 - 08/2005
21Drug Therapy (Chemotherapy)
04/2024 - 03/2010
14Hematopoietic Stem Cell Transplantation
01/2023 - 03/2010
10Deep Brain Stimulation
10/2023 - 01/2021
10Radiotherapy
07/2022 - 08/2010
9Transplantation
12/2023 - 03/2010
8Immunotherapy
11/2023 - 06/2012
7Castration
12/2019 - 01/2016
3Stem Cell Transplantation
04/2024 - 02/2012
3Aftercare (After-Treatment)
11/2023 - 08/2011
3Stents
01/2023 - 11/2021